Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 14 studies | 51% ± 23% | |
endothelial cell of lymphatic vessel | 13 studies | 36% ± 20% | |
macrophage | 5 studies | 37% ± 11% | |
platelet | 4 studies | 23% ± 6% | |
basal cell | 4 studies | 33% ± 27% | |
fibroblast | 4 studies | 24% ± 6% | |
Mueller cell | 4 studies | 35% ± 28% | |
epithelial cell | 3 studies | 32% ± 11% | |
megakaryocyte | 3 studies | 49% ± 15% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 39% ± 14% |
Insufficient scRNA-seq data for expression of STON2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1645.42 | 651 / 653 | 87% | 7.86 | 528 / 605 |
kidney | 100% | 1480.75 | 89 / 89 | 85% | 12.90 | 763 / 901 |
brain | 87% | 2513.42 | 2299 / 2642 | 97% | 20.80 | 685 / 705 |
lung | 99% | 820.22 | 574 / 578 | 72% | 10.78 | 837 / 1155 |
ovary | 69% | 323.77 | 124 / 180 | 99% | 21.36 | 425 / 430 |
breast | 86% | 556.63 | 393 / 459 | 76% | 8.49 | 851 / 1118 |
esophagus | 63% | 869.47 | 906 / 1445 | 89% | 20.27 | 162 / 183 |
bladder | 67% | 516.71 | 14 / 21 | 74% | 9.94 | 374 / 504 |
spleen | 100% | 2588.56 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.70 | 1 / 1 |
uterus | 14% | 78.33 | 23 / 170 | 86% | 15.59 | 396 / 459 |
intestine | 63% | 297.56 | 613 / 966 | 34% | 1.83 | 180 / 527 |
muscle | 96% | 1118.69 | 767 / 803 | 0% | 0 | 0 / 0 |
prostate | 59% | 311.68 | 145 / 245 | 32% | 1.95 | 161 / 502 |
skin | 72% | 739.42 | 1306 / 1809 | 11% | 0.80 | 50 / 472 |
adipose | 77% | 456.47 | 932 / 1204 | 0% | 0 | 0 / 0 |
stomach | 35% | 167.04 | 126 / 359 | 42% | 2.49 | 121 / 286 |
pancreas | 0% | 0 | 0 / 328 | 69% | 4.48 | 123 / 178 |
liver | 31% | 110.95 | 69 / 226 | 13% | 0.76 | 54 / 406 |
heart | 39% | 178.66 | 338 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 3% | 10.21 | 9 / 258 | 25% | 1.68 | 57 / 230 |
blood vessel | 20% | 92.10 | 271 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 9.29 | 26 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048488 | Biological process | synaptic vesicle endocytosis |
GO_0072583 | Biological process | clathrin-dependent endocytosis |
GO_0030100 | Biological process | regulation of endocytosis |
GO_0005730 | Cellular component | nucleolus |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0005829 | Cellular component | cytosol |
GO_0030122 | Cellular component | AP-2 adaptor complex |
GO_0043005 | Cellular component | neuron projection |
GO_0005515 | Molecular function | protein binding |
GO_0035615 | Molecular function | clathrin adaptor activity |
Gene name | STON2 |
Protein name | Stonin-2 Stonin 2 Stonin-2 (Stoned B) STON2 protein |
Synonyms | STNB STN2 |
Description | FUNCTION: Adapter protein involved in endocytic machinery. Involved in the synaptic vesicle recycling. May facilitate clathrin-coated vesicle uncoating. . FUNCTION: Adapter protein involved in endocytic machinery. Involved in the synaptic vesicle recycling. May facilitate clathrin-coated vesicle uncoating. . FUNCTION: Adapter protein involved in endocytic machinery. Involved in the synaptic vesicle recycling. May facilitate clathrin-coated vesicle uncoating. . |
Accessions | ENST00000555447.5 [Q8WXE9-3] A0A3B3IU55 Q6NT15 Q17R23 ENST00000649389.1 ENST00000553821.3 Q6NT31 ENST00000614646.5 H0YJ05 Q6NT53 Q8WXE9 |